Foregrounding the Research of Academics in Palestine
Penehyclidine Hydrochloride: A Promising Antimuscarinic Agent for PONV Prophylaxis in Diverse Surgical Procedures
Blank
Al-Azhar University – Gaza
Abo Zeid M.; El-Nablaway M.; Elrosasy A.; Hawas Y.; Aissa S.C.; Sarhan K.; Abu Salah M.A.; AlHussaini K.I.; Saber T.; Khodeer D.M.; Alkheder A.
Abo Zeid, Mohamed (58866318400); El-Nablaway, Mohammad (57220186518); Elrosasy, Amr (58299324200); Hawas, Yousef (58169674900); Aissa, Sara Chikh (59522153600); Sarhan, Khalid (57190489639); Abu Salah, Mariam A. (59522153700); AlHussaini, Khalid I. (56741258900); Saber, Taisir (56165404000); Khodeer, Dina M. (57189040909); Alkheder, Ahmad (58114525200)
Penehyclidine Hydrochloride: A Promising Antimuscarinic Agent for PONV Prophylaxis in Diverse Surgical Procedures
40
4
1043
1.05E+04
W.B. Saunders
Faculty of Medicine Tanta University, Tanta, Egypt; Department of Basic Medical Sciences, College of Medicine, AlMaarefa University, Riyadh, Saudi Arabia; Faculty of Medicine, Cairo University, Cairo, Egypt; Mohamed Lamine Debaghine University Hospital Algiers, GP-Bab El Oued, Algeria; Faculty of Medicine, Mansoura University, Mansoura, Egypt; Al Quds University Palestine Faculty of Medicine, Al Azhar Branch, Gaza, Palestine; Department of Internal Medicine, College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia; Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, Taif, Saudi Arabia; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Suez Canal University, Ismailia, Egypt; Department of Otorhinolaryngology, Al Mouwasat University Hospital, Faculty of Medicine, Damascus University, Damascus, Syrian Arab Republic; Faculty of Medicine, Syrian Private University, Damascus, Syrian Arab Republic; Medical Research Group of Egypt (MRGE), Negida Academy, Arlington, MA, United States
Abo Zeid M., Faculty of Medicine Tanta University, Tanta, Egypt, Medical Research Group of Egypt (MRGE), Negida Academy, Arlington, MA, United States; El-Nablaway M., Department of Basic Medical Sciences, College of Medicine, AlMaarefa University, Riyadh, Saudi Arabia; Elrosasy A., Faculty of Medicine, Cairo University, Cairo, Egypt; Hawas Y., Faculty of Medicine Tanta University, Tanta, Egypt; Aissa S.C., Mohamed Lamine Debaghine University Hospital Algiers, GP-Bab El Oued, Algeria; Sarhan K., Faculty of Medicine, Mansoura University, Mansoura, Egypt; Abu Salah M.A., Al Quds University Palestine Faculty of Medicine, Al Azhar Branch, Gaza, Palestine; AlHussaini K.I., Department of Internal Medicine, College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia; Saber T., Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, Taif, Saudi Arabia; Khodeer D.M., Department of Pharmacology and Toxicology, Faculty of Pharmacy, Suez Canal University, Ismailia, Egypt; Alkheder A., Department of Otorhinolaryngology, Al Mouwasat University Hospital, Faculty of Medicine, Damascus University, Damascus, Syrian Arab Republic, Faculty of Medicine, Syrian Private University, Damascus, Syrian Arab Republic
1
10.1016/j.jopan.2024.10.007
anesthesia; penehyclidine; postoperative nausea and vomiting; surgery
Antiemetics; Humans; Muscarinic Antagonists; Postoperative Nausea and Vomiting; Quinuclidines; Randomized Controlled Trials as Topic; antiemetic agent; muscarinic receptor blocking agent; penehyclidine; quinuclidine derivative; human; meta analysis; postoperative nausea and vomiting; prevention and control; randomized controlled trial (topic)